IPOPLUS

₹1,369.8

▼ -6.6 -0.48%

18 Jun 2026

NSE Listed · Pharmaceuticals

Laurus Labs Limited (LAURUSLABS)

Volume: 1,91,340Avg Vol 1W: 6,04,276Avg Vol 1M: 9,17,81252W Range:₹641.05₹1,457
NSE BSE
₹1,369.8▼ 0.48%
Key Ratios
Updated just now
Market Cap₹75,316 Cr
Current Price₹1,369.8
Previous Close₹1,376.4
High / Low (52w)₹1,457 / ₹641.05
Volume1,91,340
Avg Vol (1W)6,04,276
Avg Vol (1M)9,17,812
Stock P/E60.26
Book Value₹98.18
Dividend Yield0.14%
ROE16.77%
ROA8.47%
Revenue (TTM)—
Revenue Growth22.67%
Profit Margin13.05%
Total Debt₹611 Cr
Shares Outstanding54 Cr
Face Value₹2
EPS (TTM)₹5.17
P/B12.9
Debt / Equity0.48
50 DMA₹1,365.45
200 DMA₹1,126.15
Day change-0.48%
Price Chart
₹1,369.8▲ 48.09% · 1Y
₹1447₹81387.8L
2025-10-21
2026-06-16

20-day avg volume: 8.6L shares

Pros
  • Healthy return on equity of 16.8%.
  • Company is almost debt-free.
  • Revenue grew 22% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 60.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1,812 Cr₹1,778 Cr₹1,653 Cr₹1,570 Cr₹1,720 Cr₹1,415 Cr₹1,224 Cr₹1,195 Cr₹1,440 Cr₹1,195 Cr₹1,224 Cr₹1,182 Cr₹1,381 Cr₹1,545 Cr₹1,576 Cr₹1,539 Cr₹1,425 Cr₹1,029 Cr₹1,203 Cr₹1,279 Cr₹1,412 Cr₹1,288 Cr₹1,139 Cr₹974 Cr₹839 Cr
EBITDA₹402 Cr₹365 Cr₹310 Cr₹276 Cr₹369 Cr₹188 Cr₹75 Cr₹68 Cr₹158 Cr₹85 Cr₹96 Cr₹80 Cr₹200 Cr₹321 Cr₹368 Cr₹385 Cr₹332 Cr₹227 Cr₹285 Cr₹343 Cr₹423 Cr₹382 Cr₹328 Cr₹237 Cr₹147 Cr
Net Profit₹279 Cr₹252 Cr₹195 Cr₹163 Cr₹234 Cr₹92 Cr₹20 Cr₹13 Cr₹76 Cr₹23 Cr₹37 Cr₹25 Cr₹103 Cr₹203 Cr₹233 Cr₹251 Cr₹231 Cr₹154 Cr₹202 Cr₹241 Cr₹297 Cr₹273 Cr₹242 Cr₹172 Cr₹110 Cr
EPS5.174.653.613.024.331.710.370.231.40.430.680.461.93.764.324.664.282.853.744.485.535.074.53.212.06
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹6,868 Cr₹5,629 Cr₹5,067 Cr₹6,047 Cr₹4,951 Cr₹4,837 Cr₹2,838 Cr
EBITDA₹1,353 Cr₹700 Cr₹419 Cr₹1,274 Cr₹1,186 Cr₹1,369 Cr₹383 Cr
Net Profit₹889 Cr₹358 Cr₹161 Cr₹790 Cr₹828 Cr₹984 Cr₹255 Cr
EPS16.456.642.9714.6415.3518.284.79
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹10,511 Cr₹9,336 Cr₹8,387 Cr₹7,660 Cr₹6,968 Cr₹5,751 Cr₹3,750 Cr
Total Liabilities₹5,080 Cr₹4,733 Cr₹4,271 Cr₹3,612 Cr₹3,609 Cr₹3,150 Cr₹1,981 Cr
Equity₹5,431 Cr₹4,603 Cr₹4,116 Cr₹4,049 Cr₹3,359 Cr₹2,601 Cr₹1,770 Cr
Total Debt₹611 Cr₹646 Cr₹798 Cr₹761 Cr₹596 Cr₹429 Cr₹165 Cr
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹1,917 Cr₹739 Cr₹770 Cr₹1,279 Cr₹1,093 Cr₹962 Cr₹387 Cr
Investing₹-1,089 Cr₹-682 Cr₹-822 Cr₹-996 Cr₹-914 Cr₹-941 Cr₹-221 Cr
Financing₹-525 Cr₹39 Cr₹250 Cr₹-27 Cr₹30 Cr₹255 Cr₹-128 Cr
Free Cash Flow₹1,917 Cr₹739 Cr₹770 Cr₹1,279 Cr₹1,093 Cr₹962 Cr₹387 Cr
Shareholding
Promoter 27.49% Institutions 39.79% Public 32.71%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search